Daré Bioscience, Inc.DARENASDAQ

Revenue (LTM)

$9784

-99.7% YoY

Net Income (LTM)

$-4M

+86.6% YoY

Free Cash Flow

$5M

Revenue CAGR (5Y)

—

Marginsdeclining

FCFTurned positive

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	0	0	10	3↓71.9%	0↓99.7%
Gross Profit	-0	-0↓20.0%	-20↓20042.2%	-19↑6.5%	-14↑24.1%
Operating Income	-27	-39↓42.6%	-31↑19.7%	-31↑1.4%	-23↑24.2%
Net Income	-27	-39↓41.2%	-31↑20.0%	-30↑2.5%	-4↑86.6%
EBITDA	-27	-39↓42.7%	-31↑19.7%	-31↑2.1%	-23↑23.8%
EPS Diluted	-10.93	-7.52↑31.2%	-4.39↑41.6%	-4.15↑5.5%	-0.48↑88.4%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	5	52↑1006.6%	35↓32.9%	10↓69.8%	16↑49.8%
Total Current Assets	7	55↑691.8%	43↓22.2%	18↓59.2%	18↑5.2%
Total Assets	8	56↑639.1%	44↓21.5%	21↓51.4%	22↑3.8%
Total Current Liabilities	8	16↑109.6%	32↑97.0%	20↓35.2%	22↑5.5%
Total Liabilities	9	17↑96.0%	33↑91.8%	26↓19.5%	28↑6.8%
Total Equity	-1	39↑3464.9%	11↓71.3%	-5↓145.4%	-6↓19.1%
Total Debt	1	0↓64.3%	0↑80.6%	1↑187.4%	1↓7.2%
Net Debt	-4	-51↓1213.8%	-34↑33.5%	-9↑73.5%	-14↓58.7%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-25	-29↓14.0%	-18↑37.1%	-39↓114.8%	5↑113.9%
Capital Expenditure	-0	-0↑17.6%	-0↓334.2%	-1↓898.0%	-1↑9.0%
Free Cash Flow	-25	-29↓14.0%	-18↑36.9%	-39↓117.5%	5↑112.2%
Stock-Based Comp	1	2↑115.6%	2↑34.9%	3↑17.2%	2↓12.9%
Net Change in Cash	-0	47↑42584.3%	-17↓136.2%	-24↓40.3%	5↑121.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance